PROTAGONIST THERAPEUTICS INC shareholders Q3 2023

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.

PROTAGONIST THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$40,852,37215.05%
Kynam Capital Management, LP 1,818,657$30,335,1994.96%
BVF INC/IL 5,744,848$95,824,0652.58%
Ghost Tree Capital, LLC 400,000$6,672,0002.19%
COWEN AND COMPANY, LLC 1,657,551$27,647,9501.93%
RTW INVESTMENTS, LP 5,415,514$90,330,7741.91%
Sio Capital Management, LLC 248,127$4,138,7581.28%
683 Capital Management, LLC 732,784$12,222,8370.95%
Artia Global Partners LP 112,340$1,873,8310.78%
Perceptive Advisors 1,054,273$17,585,2740.59%
BRAIDWELL LP 1,109,150$18,500,6220.58%
MANGROVE PARTNERS IM, LLC 439,314$7,327,7580.55%
Birchview Capital, LP 38,000$633,8400.54%
FARALLON CAPITAL MANAGEMENT LLC 5,446,430$90,846,4520.46%
AlphaCentric Advisors LLC 43,500$725,5800.41%
Eversept Partners, LP 286,748$4,782,9570.40%
Knott David M Jr 52,368$8730.33%
Gratus Capital, LLC 292,869$4,885,0550.33%
MOODY ALDRICH PARTNERS LLC 68,968$1,150,3860.22%
READYSTATE ASSET MANAGEMENT LP 184,347$3,074,9080.15%
External links

This page lists PROTAGONIST THERAPEUTICS INC's shareholders in Q3 2023. To view PROTAGONIST THERAPEUTICS INC's shareholder history, click here.